In vitro diagnostic test for identifying genetic biomarkers that predict treatment response in cancer patients. Guides selection of targeted therapies and treatment protocols.
Manufactured by
Wuhan YZY Medical Science and Technology Co.,Ltd.
China
YZY Medical is a high-tech enterprise specializing in personalized molecular diagnostics for cardiovascular and oncology applications. The company has developed 160+ genetic diagnostic products and multiple IVD devices, with 14 molecular diagnostic kits holding NMPA Class III registration. Technical platforms include ARMS qPCR, multiplex qPCR, mass spectrometry, FISH, and circulating tumor cell detection. The company operates a 2,000 sqm R&D center and 3,200 sqm GMP production facility with ISO13485:2016 and CE certifications.
© 2026 Suplivia · Home · Browse Products